Starving in the land of plenty: the challenge of studying menstruation in anticoagulated patients Bethany Samuelson Bannow MD, MCR Saskia Middeldorp ISTH rpthjournal.org/article/S2475-…

New📰Helping ourselves, helping others: the Young Women's Breast Cancer Study - a multisite prospective cohort study to advance the understanding of #BreastCancerdiagnosed in women aged 40 years and younger. Read it here👇 pubmed.ncbi.nlm.nih.gov/38951008/

"Never-words are conversation stoppers". This is an excellent article, probing the use of language and its impact on patients, families & caregivers.

#BreastCancer in young women is often found at a later stage. Find out what factors can raise your risk of early breast #cancer. bit.ly/4dU7r6a #BringYourBrave #BYB

Addressing the Growing Challenge of Young-Onset Colorectal Cancer: The Importance of an Integrated Multidisciplinary Approach | JCO Oncology Practice ascopubs.org/doi/10.1200/OP… JCO Oncology Practice OncoAlert ASCO

Every 180 seconds, someone in the U.S. hears the words “You have blood cancer.” ❤️ With 100+ types of blood cancer affecting millions of lives, we need to bring more awareness to this disease.​ #BloodCancerAwarenessMonth is our chance to define blood cancer and redefine what’s

Cancer in a nutshell

Check out the recently published protocol for the randomized #EMBody trial looking at exercise as part of survivorship care in #MetastaticBreastCancer. 🔓pubmed.ncbi.nlm.nih.gov/39267010/ ✍️ #JenniferLigibel Niraj Shah Dr. Kelly Shanahan Lesley Kailani Glenn Tarah Ballinger, MD #MBC #BreastCancer

‼️ New findings from American Cancer Society today show that #BreastCancer rates continue to rise at a faster pace in women younger than 50 years compared to those 50 or older. Read the free report: acsjournals.onlinelibrary.wiley.com/doi/full/10.33… OncoAlert #BreastCancerAwarenessMonth #BCSM

Half of people with inherited BRCA1/2 mutations are men, yet very few men are offered genetic testing or know the importance to their own health. Article reviews data & screening recommendations aimed to help men take action to reduce their risk of cancer. ja.ma/3TV8WbG

We are deeply saddened by the passing of Mr Ratan Tata. A visionary leader with the highest integrity, but also an incredibly compassionate person. Truly a nation builder. Tata Memorial Hospital is indebted to him for his sustained support over the decades.

This study evaluated survival benefit of smoking cessation among 6,593 patients w/ cancer treated in the Tobacco Research and Treatment Program (TRTP) at MD Anderson Cancer Center, providing evidence that quitting smoking at diagnosis improves survival. ja.ma/4f3vyPW

What are those beautiful lung pins that you have been seeing around? That’s part of OUR campaign to increase awareness about lung cancer in women the #HearHer campaign In our LEAD study we observed that women take longer to get to a LC diagnosis - leading to ⬆️ stage

It's #WorldCancerDay. Here are ways to reduce your #cancer risk: 🚭Don't use tobacco 🏃🏽‍♂️Exercise regularly and be physically active ✅Keep a healthy weight 🥗Eat a healthy diet with a variety of fruit and vegetables 🕶Avoid strong sunlight for prolonged periods and limit

Today is #WorldCancerDay! NCCN joins today’s global day of advocacy to put people’s individual needs and stories at the forefront of cancer care. Learn more at: NCCN.org/wcd #UnitedbyUnique

📢CAR T-cells for relapsed/refractory B-cell malignancies in India: phase 1/2 trial 📈Safety: no ICANS, low incidence of severe CRS, manageable haematological toxicities, 2 treatment-related deaths. 🔍Activity: 73% overall response rate.Rahul Purwar 👇 shorturl.at/x11Ip

BREAKING from NEJM In cancer patients w/ Cancer-Associated Venous Thromboembolism, reduced-dose apixaban (2.5 mg BID) is : 🔘Noninferior to full-dose (5 mg BID) for VTE recurrence 🔘Lower bleeding risk (12.1% vs. 15.6%) 🔘Safer extended anticoagulation, same protection.

Assessment of a Polygenic Risk Score in Screening for Prostate Cancer (BARCODE1) out on NEJM nejm.org/doi/full/10.10… Study evaluated a targeted #ProstateCancer screening approach using polygenic risk scores derived from 130 known genetic variants, identifying men aged 55–69 in

Cancer-Related Cognitive Impairment: A Practical Guide for Oncologists | JCO Oncology Practice ascopubs.org/doi/10.1200/OP… JCO Oncology Practice OncoAlert #JCOOP